News
SZA has criticised users of AI for being "codependent on a machine", despite the technology's energy consumption and pollution.
Researchers at the University of Tennessee are using AI and a new tool to determine how much breast cancer is in a patient's body.
Seven biotech unicorns are advancing AI-powered drug discovery and development—but must contend with a difficult investing ...
The FDA clears GL-IL2-138, a groundbreaking oral drug modulating natural IL-2, set to revolutionize treatment in oncology.
In this week’s edition of InnovationRx, we look at how Daniel Nadler became a billionaire building a ChatGPT for doctors, big news from two Chinese biotech companies, what doctors think about AI and ...
In their appeal, the NAACP and other groups argued that the SCHD put xAI profits over Black people's health, granting ...
Alphabet spinoff SandboxAQ is teaming up with iOncologi to build a new mRNA vaccine for a common and aggressive brain tumor ...
Researchers compared radiologist performance and visual search patterns when reading screening mammograms with and without an AI decision support system.
Revolution Medicines, Inc. (NASDAQ: RVMD) is one of the best oversold NASDAQ stocks to buy now. On July 15, Goldman Sachs ...
Soon, many patients might initiate contact with the health system not by speaking with a call center worker or receptionist, ...
University of Tennessee researchers are using artificial intelligence to more quickly determine treatment plans for breast cancer patients.
As cancer cases have increased worldwide, the disease has become more complex, presenting challenges to scientific advances in diagnosis and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results